Looking ahead: A case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy

Keyphrases

• Advocacy Groups 33%
• Awareness Development 33%
• Bioassay Test 33%
• Cervical Cancer Incidence 33%
• Cervical Cancer Prevention 33%
• Cervical Cancer Screening 100%
• CIN2+ 66%
• Community Advocacy 33%
• Community Awareness 33%
• Community Education 33%
• Developing World 33%
• Diagnostic Test 33%
• DNA Testing 33%
• Early Detection 33%
• Early Treatment 33%
• Education Development 33%
• Effective Programs 33%
• Effective Treatment 33%
• Health Centers 33%
• Health Translation 33%
• High-risk Human Papillomavirus (HR-HPV) 66%
• Highly Effective 33%
• Human Papillomavirus DNA 33%
• Human Papillomavirus Testing 100%
• Pap Test 33%
• Precursor Lesions 33%
• Primary Screening 66%
• Prophylactic Vaccine 33%
• Public Health 33%
• Screen Positive 33%
• Screening Activity 33%
• Screening Assays 33%
• Screening Diagnosis 33%
• Screening Strategy 100%
• Self-collected 33%
• Substantial Reduction 33%
• Targeted Population 33%
• Technologic 33%
• Testing Strategy 33%
• Vaccination 33%
• Vaginal Specimens 100%

Medicine and Dentistry

• Awareness 16%
• Cancer Mortality 16%
• Cervical Cancer 16%
• Cervical Cancer Prevention 16%
• Cervical Cancer Screening 100%
• Cytotechnology 16%
• Diagnostic Test 16%
• DNA Screening 16%
• Health Care 16%
• Lifespan 16%
• Papanicolaou Stain 16%
• Precursor 16%
• Public Health 16%
• Screening 16%
• Sensitivity and Specificity 16%
• Wart Virus 100%